- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.05. | How to manage the complexities of synthetic API production in 30 steps | ||
| 14.05. | GSK to spend $2bn on Phase III liver disease drug acquisition | ||
| 14.05. | Stylus Medicine launches with $85m to advance in vivo gene editing | ||
| 14.05. | Eligo Bioscience secures grant to advance topical gene delivery platform | ||
| 14.05. | GSK and iTeos drop anti-TIGIT drug following trial failure | ||
| 14.05. | Japan's MHLW approves Sarepta's gene therapy for DMD | ||
| 13.05. | Orphan drug market access in Europe: HTA challenges and the growing potential of RWE | ||
| 13.05. | Reducing patient burden in rare disease trials: DCTs for increased patient centricity | ||
| 13.05. | FDA clears Ensoma's application for rare genetic disorder treatment | ||
| 13.05. | How to transform EHR data into useful clinical insights using AI | ||
| 13.05. | Pharma faces 30-day deadline under Trump's pricing order | ||
| 13.05. | EC grants orphan drug status to Biodexa's oral FAP treatment | ||
| 13.05. | Republicans' proposed Medicaid cuts met with dismay | ||
| 13.05. | Abeona secures cash runway with $155m priority review voucher sale | ||
| 13.05. | GLP-1RAs show anti-cancer benefits beyond weight loss | ||
| 13.05. | MHRA approves AstraZeneca's Trixeo Aerosphere inhaler for COPD | ||
| 12.05. | Roche plans $700m manufacturing plant in the US | ||
| 12.05. | Novo Nordisk's Sogroya matches Norditropin in children's growth disorders | ||
| 12.05. | Minghui and Qilu Pharmaceutical to advance MHB088C in Greater China | ||
| 12.05. | The advantages of isolator lines for large-scale pharma manufacturing | ||
| 12.05. | Trump to sign order tying US drug prices to global rates | ||
| 12.05. | LENZ and Lotus Pharmaceutical collaborate to commercialise presbyopia treatment | ||
| 12.05. | Valneva's chikungunya vaccine use halted in older adults amid safety concerns | ||
| 12.05. | Lilly-Purdue partnership to invest $250m in pharma innovation | ||
| 12.05. | American Academy of Neurology (AAN) Annual Meeting 2025 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .